vs
科睿唯安（CLVT）与CoStar Group（CSGP）财务数据对比。点击上方公司名可切换其他公司
CoStar Group的季度营收约是科睿唯安的1.5倍（$899.9M vs $617.0M），CoStar Group净利率更高（5.2% vs 0.5%，领先4.7%），CoStar Group同比增速更快（26.9% vs -6.9%），CoStar Group自由现金流更多（$101.3M vs $89.2M），过去两年CoStar Group的营收复合增速更高（17.1% vs -0.3%）
科睿唯安是一家英美合资的上市分析服务企业，主要提供订阅制信息服务，覆盖文献计量、科学计量、商业与市场情报领域，同时为医药、生物科技行业提供专利、监管合规相关的竞争分析，也提供商标保护、域名与品牌保护服务，旗下Web of Science产品系列还负责计算学术期刊的影响因子。
CoStar Group是1987年成立的美国商业地产服务商，总部位于弗吉尼亚州阿灵顿，业务覆盖北美、欧洲地区，为商业地产行业提供信息、分析及营销解决方案，旗下运营CoStar线上数据库、新闻网站及Apartments.com、Homes.com等多个线上平台。
CLVT vs CSGP — 直观对比
营收规模更大
CSGP
是对方的1.5倍
$617.0M
营收增速更快
CSGP
高出33.8%
-6.9%
净利率更高
CSGP
高出4.7%
0.5%
自由现金流更多
CSGP
多$12.1M
$89.2M
两年增速更快
CSGP
近两年复合增速
-0.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $617.0M | $899.9M |
| 净利润 | $3.1M | $46.5M |
| 毛利率 | 66.8% | 78.6% |
| 营业利润率 | 6.7% | 5.5% |
| 净利率 | 0.5% | 5.2% |
| 营收同比 | -6.9% | 26.9% |
| 净利润同比 | 101.6% | -22.2% |
| 每股收益（稀释后） | $0.00 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLVTCSGP
| Q4 25 | $617.0M | $899.9M | ||
| Q3 25 | $623.1M | $833.6M | ||
| Q2 25 | $621.4M | $781.3M | ||
| Q1 25 | $593.7M | $732.2M | ||
| Q4 24 | $663.0M | $709.4M | ||
| Q3 24 | $622.2M | $692.6M | ||
| Q2 24 | $650.3M | $677.8M | ||
| Q1 24 | $621.2M | $656.4M |
净利润CLVTCSGP
| Q4 25 | $3.1M | $46.5M | ||
| Q3 25 | $-28.3M | $-30.9M | ||
| Q2 25 | $-72.0M | $6.2M | ||
| Q1 25 | $-103.9M | $-14.8M | ||
| Q4 24 | $-191.8M | $59.8M | ||
| Q3 24 | $-65.6M | $53.0M | ||
| Q2 24 | $-304.3M | $19.2M | ||
| Q1 24 | $-75.0M | $6.7M |
毛利率CLVTCSGP
| Q4 25 | 66.8% | 78.6% | ||
| Q3 25 | 65.0% | 79.3% | ||
| Q2 25 | 67.2% | 78.5% | ||
| Q1 25 | 65.1% | 79.1% | ||
| Q4 24 | 65.7% | 80.1% | ||
| Q3 24 | 66.2% | 79.7% | ||
| Q2 24 | 67.2% | 80.0% | ||
| Q1 24 | 64.9% | 78.5% |
营业利润率CLVTCSGP
| Q4 25 | 6.7% | 5.5% | ||
| Q3 25 | 7.1% | -6.1% | ||
| Q2 25 | 1.1% | -3.5% | ||
| Q1 25 | -3.5% | -5.8% | ||
| Q4 24 | -9.4% | 5.6% | ||
| Q3 24 | 3.5% | 3.4% | ||
| Q2 24 | -36.9% | -2.4% | ||
| Q1 24 | 0.8% | -6.5% |
净利率CLVTCSGP
| Q4 25 | 0.5% | 5.2% | ||
| Q3 25 | -4.5% | -3.7% | ||
| Q2 25 | -11.6% | 0.8% | ||
| Q1 25 | -17.5% | -2.0% | ||
| Q4 24 | -28.9% | 8.4% | ||
| Q3 24 | -10.5% | 7.7% | ||
| Q2 24 | -46.8% | 2.8% | ||
| Q1 24 | -12.1% | 1.0% |
每股收益（稀释后）CLVTCSGP
| Q4 25 | $0.00 | $0.12 | ||
| Q3 25 | $-0.04 | $-0.07 | ||
| Q2 25 | $-0.11 | $0.01 | ||
| Q1 25 | $-0.15 | $-0.04 | ||
| Q4 24 | $-0.27 | $0.14 | ||
| Q3 24 | $-0.09 | $0.13 | ||
| Q2 24 | $-0.46 | $0.05 | ||
| Q1 24 | $-0.14 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $329.2M | $1.6B |
| 总债务越低越好 | $4.3B | $140.0M |
| 股东权益账面价值 | $4.8B | $8.3B |
| 总资产 | $11.1B | $10.5B |
| 负债/权益比越低杠杆越低 | 0.89× | 0.02× |
8季度趋势，按日历期对齐
现金及短期投资CLVTCSGP
| Q4 25 | $329.2M | $1.6B | ||
| Q3 25 | $318.7M | $1.9B | ||
| Q2 25 | $362.6M | $3.6B | ||
| Q1 25 | $354.0M | $3.7B | ||
| Q4 24 | $295.2M | $4.7B | ||
| Q3 24 | $388.5M | — | ||
| Q2 24 | $376.4M | — | ||
| Q1 24 | $361.8M | — |
总债务CLVTCSGP
| Q4 25 | $4.3B | $140.0M | ||
| Q3 25 | $4.4B | $1.0B | ||
| Q2 25 | $4.5B | $1.0B | ||
| Q1 25 | $4.5B | $1.0B | ||
| Q4 24 | $4.5B | $1.0B | ||
| Q3 24 | $4.6B | $1.0B | ||
| Q2 24 | $4.6B | $1.0B | ||
| Q1 24 | $4.6B | $1.0B |
股东权益CLVTCSGP
| Q4 25 | $4.8B | $8.3B | ||
| Q3 25 | $4.9B | $8.6B | ||
| Q2 25 | $5.0B | $8.6B | ||
| Q1 25 | $5.0B | $8.6B | ||
| Q4 24 | $5.1B | $7.6B | ||
| Q3 24 | $5.5B | $7.5B | ||
| Q2 24 | $5.6B | $7.4B | ||
| Q1 24 | $5.9B | $7.3B |
总资产CLVTCSGP
| Q4 25 | $11.1B | $10.5B | ||
| Q3 25 | $11.2B | $10.8B | ||
| Q2 25 | $11.4B | $10.5B | ||
| Q1 25 | $11.5B | $10.4B | ||
| Q4 24 | $11.5B | $9.3B | ||
| Q3 24 | $12.0B | $9.1B | ||
| Q2 24 | $12.1B | $9.1B | ||
| Q1 24 | $12.5B | $9.0B |
负债/权益比CLVTCSGP
| Q4 25 | 0.89× | 0.02× | ||
| Q3 25 | 0.90× | 0.12× | ||
| Q2 25 | 0.90× | 0.12× | ||
| Q1 25 | 0.90× | 0.12× | ||
| Q4 24 | 0.88× | 0.13× | ||
| Q3 24 | 0.84× | 0.13× | ||
| Q2 24 | 0.83× | 0.14× | ||
| Q1 24 | 0.79× | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $159.9M | $162.1M |
| 自由现金流经营现金流 - 资本支出 | $89.2M | $101.3M |
| 自由现金流率自由现金流/营收 | 14.5% | 11.3% |
| 资本支出强度资本支出/营收 | 11.5% | 6.8% |
| 现金转化率经营现金流/净利润 | 51.58× | 3.49× |
| 过去12个月自由现金流最近4个季度 | $365.3M | $123.0M |
8季度趋势，按日历期对齐
经营现金流CLVTCSGP
| Q4 25 | $159.9M | $162.1M | ||
| Q3 25 | $181.1M | $68.2M | ||
| Q2 25 | $116.3M | $146.5M | ||
| Q1 25 | $171.2M | $53.2M | ||
| Q4 24 | $141.3M | $94.6M | ||
| Q3 24 | $202.9M | $100.3M | ||
| Q2 24 | $126.2M | $58.1M | ||
| Q1 24 | $176.2M | $139.6M |
自由现金流CLVTCSGP
| Q4 25 | $89.2M | $101.3M | ||
| Q3 25 | $115.5M | $-5.5M | ||
| Q2 25 | $50.3M | $27.7M | ||
| Q1 25 | $110.3M | $-500.0K | ||
| Q4 24 | $59.1M | $25.2M | ||
| Q3 24 | $126.3M | $40.2M | ||
| Q2 24 | $60.3M | $-14.7M | ||
| Q1 24 | $111.8M | $-237.1M |
自由现金流率CLVTCSGP
| Q4 25 | 14.5% | 11.3% | ||
| Q3 25 | 18.5% | -0.7% | ||
| Q2 25 | 8.1% | 3.5% | ||
| Q1 25 | 18.6% | -0.1% | ||
| Q4 24 | 8.9% | 3.6% | ||
| Q3 24 | 20.3% | 5.8% | ||
| Q2 24 | 9.3% | -2.2% | ||
| Q1 24 | 18.0% | -36.1% |
资本支出强度CLVTCSGP
| Q4 25 | 11.5% | 6.8% | ||
| Q3 25 | 10.5% | 8.8% | ||
| Q2 25 | 10.6% | 15.2% | ||
| Q1 25 | 10.3% | 7.3% | ||
| Q4 24 | 12.4% | 9.8% | ||
| Q3 24 | 12.3% | 8.7% | ||
| Q2 24 | 10.1% | 10.7% | ||
| Q1 24 | 10.4% | 57.4% |
现金转化率CLVTCSGP
| Q4 25 | 51.58× | 3.49× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 23.63× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.58× | ||
| Q3 24 | — | 1.89× | ||
| Q2 24 | — | 3.03× | ||
| Q1 24 | — | 20.84× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLVT
| Academia Government Group | $312.3M | 51% |
| Re Occurring Revenues | $114.1M | 18% |
| Life Sciences And Healthcare Group | $98.3M | 16% |
| Transactional Revenues | $97.1M | 16% |
CSGP
| Co Star | $503.8M | 56% |
| Other | $283.0M | 31% |
| Loop Net | $94.7M | 11% |
